Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-12-01FDA Approved: ALBUTEROL SULFATE INHALATION — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal's albuterol sulfate inhalation as a generic inhalation product under ANDA 211600 for relief of bronchospasm in reversibl…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Towards Participatory Paediatric Asthma Action Plans
Clinical trial completed evaluating participatory pediatric asthma action plans to improve asthma management.
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Breathing Parameter Measurements for Lung Deposition Simulation
A completed clinical trial evaluating breathing parameter measurements for lung deposition simulation.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A Comparison Study Between Adolescents With Asthma and Adults With Asthma on How They Absorb, Metabolise and Eliminate CHF 6001 [Phase 2]
This Phase 2 pharmacokinetic study comparing absorption, metabolism, and elimination of CHF 6001 in adolescents and adults with asthma has c…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: EmoTIChealth: Promoting Adolescent Health Through a Serious Game. [NA]
University of Valencia is testing EmoTIChealth, a serious-game intervention to promote health among adolescents with Type 1 diabetes mellitu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: The Effect of Asthma Flare-up Clinic After Exacerbation [NA]
This clinical trial update describes a study evaluating the impact of an asthma flare-up clinic after exacerbations, with recruitment curren…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion) [Phase 3]
Phase 3 trial results evaluating the safety and efficacy of dupilumab in children with asthma have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics [Phase 1]
A first-in-human, single-ascending-dose Phase 1 study of the biologic IBI3002 in healthy participants and mild-to-moderate asthmatics has co…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study [Phase 2]
A Phase 2 clinical trial evaluating soy isoflavones for inner-city infants at risk for asthma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Inducible Laryngeal Obstruction in Severe Asthma in Severe Asthma
A clinical trial studying inducible laryngeal obstruction in people with severe asthma has completed.
-
EMA approval · 2025-11-20EMA Authorised: Enerzair Breezhaler (indacaterol;glycopyrronium bromide;mometasone) — Novartis Europharm Limited
EMA authorised Enerzair Breezhaler, a fixed-dose inhaler combining indacaterol, glycopyrronium bromide, and mometasone, for asthma under Nov…
-
EMA approval · 2025-11-20EMA Authorised: Atectura Breezhaler (indacaterol acetate;mometasone furoate) — Novartis Europharm Limited
The EMA authorised Atectura Breezhaler, a combination inhaler containing indacaterol acetate and mometasone furoate, for asthma.
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma. [Phase 2]
Phase 2 trial assessing efficacy and safety of TQC2731 injection in severe asthma has completed.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers
Status update on a clinical trial studying how asthma endotypes and phenotypes develop in high-risk toddlers, with a focus on identifying cr…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease
This clinical trial update reports on the use of acoustic cough monitoring to manage patients with known respiratory diseases; the study sta…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma
An ongoing clinical trial is investigating how downstream airway mucus plugs affect Xenon-129 MRI imaging in severe asthma.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: ED-Initiated School-based Asthma Medication Supervision [Phase 4]
Phase 4 trial evaluating emergency department-initiated, school-based supervision of asthma medications; results have been posted.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma [Phase 1]
A Phase 1 study evaluating the safety and tolerability of multiple doses of IBI3002 in patients with asthma, currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Diagnostic and Translational Values of Point-of-care Blood Eosinophils and Exhaled Nitric Oxide (FeNO) in People Referred by Primary Care for Suspected Asthma
Completed clinical trial evaluating the diagnostic value of point-of-care blood eosinophil counts and exhaled nitric oxide (FeNO) in people …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Εffectiveness of a Digital Social Intervention in Primary Care [NA]
This clinical trial update describes a study evaluating the effectiveness of a digital social intervention in primary care for patients with…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Bioequivalence Study of AJU-R713 and R713R in Healthy Adult Volunteers [Phase 1]
Phase 1 bioequivalence study evaluating AJU-R713 versus R713R in healthy adult volunteers. The study is currently not yet recruiting and is …
-
EMA approval · 2025-11-18EMA Authorised: Omlyclo (omalizumab) — Celltrion Healthcare Hungary Kft.
EMA has authorised Omlyclo (omalizumab) by Celltrion Healthcare Hungary Kft. for asthma and urticaria.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Utilizing CT Based Imaging Parameters of Body Composition to Understand Heterogeneity of Response to Biologic Therapies in Severe Asthma Cohorts
Completed clinical trial evaluating CT-based body composition imaging to understand heterogeneity of response to biologic therapies in sever…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: E-cigarettes for Harm Reduction in Adults With Asthma [NA]
Completed clinical trial evaluating harm-reduction potential of e-cigarettes in adults with asthma; results were posted in November 2025.
-
CLINICAL_TRIALS withdrawal · 2025-11-18Clinical Trial Update: Impact of COVID19 on Asthma Patients in Spain
This clinical trial investigating the impact of COVID-19 on asthma patients in Spain has been withdrawn.